0001567619-21-004330.txt : 20210217
0001567619-21-004330.hdr.sgml : 20210217
20210217193544
ACCESSION NUMBER: 0001567619-21-004330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210214
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Underberg Sharon E.
CENTRAL INDEX KEY: 0001630353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 21647025
MAIL ADDRESS:
STREET 1: EASTMAN KODAK COMPANY
STREET 2: 343 STATE STREET
CITY: ROCHESTER
STATE: NY
ZIP: 14650
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2021-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001630353
Underberg Sharon E.
C/O IDEXX LABORATORIES, INC.
WESTBROOK
ME
04092
0
1
0
0
SVP, Gen. Counsel & Secretary
Common Stock
2021-02-14
4
M
0
483
0
A
1386
D
Common Stock
2021-02-14
4
M
0
217
0
A
1603
D
Common Stock
2021-02-14
4
F
0
208
544.08
D
1395
D
Non-Qualified Stock Option (right-to-buy)
544.08
2021-02-14
4
A
0
5119
A
2031-02-13
Common Stock
5119
5119
D
Incentive Stock Option (right-to-buy)
544.08
2021-02-14
4
A
0
183
A
2031-02-13
Common Stock
183
183
D
Restricted Stock Unit
2021-02-14
4
A
0
551
A
Common Stock
551
3349
D
Restricted Stock Unit
2021-02-14
4
M
0
453
D
Common Stock
453
2866
D
Restricted Stock Unit
2021-02-14
4
M
0
217
D
Common Stock
217
2649
D
Includes a total of 29 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020 and December 31, 2020.
Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
2021-02-17